Trial Profile
Prospective, randomized, open-label, clinical trial comparing rosuvastatin monotherapy and combination therapy with ezetimibe on progression of atherosclerotic plaques and endothelial function
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 May 2016
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary) ; Rosuvastatin (Primary)
- Indications Atherosclerosis; Dyslipidaemias
- Focus Therapeutic Use
- 17 Sep 2013 New trial record